{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T17:21:53Z","timestamp":1751217713907},"reference-count":70,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9214","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T07:54:05Z","timestamp":1532505245000},"source":"Crossref","is-referenced-by-count":4,"title":["Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer"],"prefix":"10.3892","author":[{"given":"Wentao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyue","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"key20200714083855_b1-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"e0123523","DOI":"10.1371\/journal.pone.0123523","article-title":"Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: A cohort study","volume":"10","author":"Seneviratne","year":"2015","journal-title":"PLoS One"},{"key":"key20200714083855_b2-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3322\/caac.21203","article-title":"Breast cancer statistics, 2013","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key20200714083855_b3-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","article-title":"Breast cancer in China","volume":"15","author":"Fan","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20200714083855_b4-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrg2554","article-title":"Human genetic variation and its contribution to complex traits","volume":"10","author":"Frazer","year":"2009","journal-title":"Nat Rev Genet"},{"key":"key20200714083855_b5-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2013.09.011","article-title":"Mapping human epigenomes","volume":"155","author":"Rivera","year":"2013","journal-title":"Cell"},{"key":"key20200714083855_b6-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic localization of common disease-associated variation in regulatory DNA","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"key":"key20200714083855_b7-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrc1799","article-title":"Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction?","volume":"6","author":"Baylin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20200714083855_b8-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nat Rev Genet"},{"key":"key20200714083855_b9-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1093\/hmg\/10.26.3001","article-title":"DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis","volume":"10","author":"Esteller","year":"2001","journal-title":"Hum Mol Genet"},{"key":"key20200714083855_b10-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng0794-376","article-title":"The distribution of CpG islands in mammalian chromosomes","volume":"7","author":"Craig","year":"1994","journal-title":"Nat Genet"},{"key":"key20200714083855_b11-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.1083557","article-title":"Chromosomal instability and tumors promoted by DNA hypomethylation","volume":"300","author":"Eden","year":"2003","journal-title":"Science"},{"key":"key20200714083855_b12-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200714083855_b13-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1101\/gr.119867.110","article-title":"A DNA methylation fingerprint of 1628 human samples","volume":"22","author":"Fernandez","year":"2012","journal-title":"Genome Res"},{"key":"key20200714083855_b14-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12864-015-1994-2","article-title":"Changes in correlation between promoter methylation and gene expression in cancer","volume":"16","author":"Moarii","year":"2015","journal-title":"BMC Genomics"},{"issue":"145\u2013153","key":"key20200714083855_b15-ol-0-0-9214","first-page":"e6","article-title":"Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome","volume":"104","author":"Yu","year":"2015","journal-title":"Fertil Steril"},{"key":"key20200714083855_b16-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"key":"key20200714083855_b17-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/pros.22459","article-title":"The epigenetic promise for prostate cancer diagnosis","volume":"72","author":"Van Neste","year":"2012","journal-title":"Prostate"},{"key":"key20200714083855_b18-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2217\/14622416.9.12.1879","article-title":"Epigenomics and breast cancer","volume":"9","author":"Lo","year":"2008","journal-title":"Pharmacogenomics"},{"key":"key20200714083855_b19-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"12969","DOI":"10.1007\/s13277-016-5169-9","article-title":"Aberrant expression and functions of protocadherins in human malignant tumors","volume":"37","author":"Shan","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200714083855_b20-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1586\/erm.13.32","article-title":"Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer","volume":"13","author":"Otani","year":"2013","journal-title":"Expert Rev Mol Diagn"},{"issue":"640\u2013651","key":"key20200714083855_b21-ol-0-0-9214","first-page":"e1","article-title":"Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer","volume":"136","author":"Yu","year":"2009","journal-title":"Gastroenterology"},{"key":"key20200714083855_b22-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/jvh.12265","article-title":"PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt\/\u03b2-catenin signalling pathway in hepatocellular carcinoma","volume":"22","author":"Lv","year":"2015","journal-title":"J Viral Hepat"},{"key":"key20200714083855_b23-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"446","DOI":"10.7150\/jca.13065","article-title":"PCDH8 is frequently inactivated by promoter hypermethylation in liver cancer: Diagnostic and clinical significance","volume":"7","author":"Zhang","year":"2016","journal-title":"J Cancer"},{"key":"key20200714083855_b24-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"75307","DOI":"10.18632\/oncotarget.12171","article-title":"Promoter methylation of PCDH10 by HOTAIR regulates the progression of gastrointestinal stromal tumors","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"key20200714083855_b25-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ijc.21054","article-title":"Identification of 20 genes aberrantly methylated in human breast cancers","volume":"116","author":"Miyamoto","year":"2005","journal-title":"Int J Cancer"},{"key":"key20200714083855_b26-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/sj.onc.1209154","article-title":"Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation","volume":"25","author":"Ying","year":"2006","journal-title":"Oncogene"},{"key":"key20200714083855_b27-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMra0802968","article-title":"Inherited susceptibility to common cancers","volume":"359","author":"Foulkes","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200714083855_b28-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","article-title":"Family history and the risk of breast cancer: A systematic review and meta-analysis","volume":"71","author":"Pharoah","year":"1997","journal-title":"Int J Cancer"},{"key":"key20200714083855_b29-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMp0708307","article-title":"\u2018Westernizing\u2019 women's risks? Breast cancer in lower-income countries","volume":"358","author":"Porter","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200714083855_b30-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1524-4741.2007.00515.x","article-title":"Hereditary breast cancer: Part I. Diagnosing hereditary breast cancer syndromes","volume":"14","author":"Lynch","year":"2008","journal-title":"Breast J"},{"key":"key20200714083855_b31-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bjps.2008.07.012","article-title":"Hereditary breast cancer syndromes and clinical implications","volume":"62","author":"Majdak-Paredes","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"key20200714083855_b32-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20200714083855_b33-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/BF02966723","article-title":"Evaluation of HER-2 status in breast carcinoma by fluorescence in situ hybridization and immunohistochemistry","volume":"10","author":"Ogura","year":"2003","journal-title":"Breast Cancer"},{"key":"key20200714083855_b34-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0046-8177(96)90282-8","article-title":"Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas","volume":"27","author":"Soong","year":"1996","journal-title":"Hum Pathol"},{"key":"key20200714083855_b35-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1200\/JCO.2008.18.1024","article-title":"Breast cancer subtypes and response to docetaxel in node-positive breast cancer: Use of an immunohistochemical definition in the BCIRG 001 trial","volume":"27","author":"Hugh","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20200714083855_b36-ol-0-0-9214","first-page":"710","article-title":"DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling","volume":"4","author":"Yu","year":"2014","journal-title":"Am J Cancer Res"},{"key":"key20200714083855_b37-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/B978-0-12-418687-3.00004-5","article-title":"Agarose gel electrophoresis","volume":"529","author":"Koontz","year":"2013","journal-title":"Methods Enzymol"},{"key":"key20200714083855_b38-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200714083855_b39-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","article-title":"MethyLight: A high-throughput assay to measure DNA methylation","volume":"28","author":"Eads","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"key20200714083855_b40-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1158\/0008-5472.CAN-06-2888","article-title":"Towards clinical application of methylated DNA sequences as cancer biomarkers: A Joint NCI's EDRN and NIST workshop on standards, methods, assays, reagents and tools","volume":"67","author":"Kagan","year":"2007","journal-title":"Cancer Res"},{"key":"key20200714083855_b41-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2353\/jmoldx.2006.050135","article-title":"Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis","volume":"8","author":"Ogino","year":"2006","journal-title":"J Mol Diagn"},{"key":"key20200714083855_b42-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1158\/0008-5472.CAN-03-3852","article-title":"Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen","volume":"64","author":"Widschwendter","year":"2004","journal-title":"Cancer Res"},{"key":"key20200714083855_b43-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/ijc.24599","article-title":"HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: A proof of principle study","volume":"125","author":"Widschwendter","year":"2009","journal-title":"Int J Cancer"},{"key":"key20200714083855_b44-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10549-011-1712-y","article-title":"Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients","volume":"131","author":"Cho","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"key20200714083855_b45-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1940-6207.CAPR-09-0098","article-title":"Strategic approach to validating methylated genes as biomarkers for breast cancer","volume":"3","author":"Wang","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20200714083855_b46-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1038\/sj.onc.1205598","article-title":"DNA methylation and gene silencing in cancer: Which is the guilty party?","volume":"21","author":"Clark","year":"2002","journal-title":"Oncogene"},{"key":"key20200714083855_b47-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/bcr2466","article-title":"Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer","volume":"12","author":"Muggerud","year":"2010","journal-title":"Breast Cancer Res"},{"key":"key20200714083855_b48-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1006\/geno.2001.6592","article-title":"Identification and characterization of three members of a novel subclass of protocadherins","volume":"76","author":"Wolverton","year":"2001","journal-title":"Genomics"},{"key":"key20200714083855_b49-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1038\/sj.onc.1207632","article-title":"The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma","volume":"23","author":"Qiu","year":"2004","journal-title":"Oncogene"},{"key":"key20200714083855_b50-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"701","DOI":"10.4161\/epi.20445","article-title":"Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen","volume":"7","author":"Jeschke","year":"2012","journal-title":"Epigenetics"},{"key":"key20200714083855_b51-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/onc.2009.493","article-title":"Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma","volume":"29","author":"Morris","year":"2010","journal-title":"Oncogene"},{"key":"key20200714083855_b52-ol-0-0-9214","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0304-2","article-title":"E-cadherin in contact inhibition and cancer","author":"Mendonsa","year":"2018","journal-title":"Oncogene"},{"key":"key20200714083855_b53-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1038\/oncsis.2015.17","article-title":"An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt\/beta-catenin-elicited promotion of the cancer stem cell phenotype","volume":"4","author":"Su","year":"2015","journal-title":"Oncogenesis"},{"key":"key20200714083855_b54-ol-0-0-9214","first-page":"1279","article-title":"Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: A role for raft proteins in cell transformation and cancer progression (review)","volume":"17","author":"Patra","year":"2007","journal-title":"Oncol Rep"},{"key":"key20200714083855_b55-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1158\/0008-5472.CAN-05-4437","article-title":"Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers","volume":"66","author":"Imoto","year":"2006","journal-title":"Cancer Res"},{"key":"key20200714083855_b56-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/carcin\/bgq053","article-title":"Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma","volume":"31","author":"Haruki","year":"2010","journal-title":"Carcinogenesis"},{"key":"key20200714083855_b57-ol-0-0-9214","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26259","article-title":"Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia","volume":"64","author":"Uyen","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"key20200714083855_b58-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3892\/or.2016.4793","article-title":"Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells","volume":"36","author":"Qiu","year":"2016","journal-title":"Oncol Rep"},{"key":"key20200714083855_b59-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/15384101.2015.1004935","article-title":"PCDH10, a novel p53 transcriptional target in regulating cell migration","volume":"14","author":"Shi","year":"2015","journal-title":"Cell Cycle"},{"key":"key20200714083855_b60-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.yexmp.2016.03.002","article-title":"Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma","volume":"100","author":"Yang","year":"2016","journal-title":"Exp Mol Pathol"},{"key":"key20200714083855_b61-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1111\/j.1349-7006.2009.01285.x","article-title":"Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings","volume":"100","author":"Wang","year":"2009","journal-title":"Cancer Sci"},{"key":"key20200714083855_b62-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/CBM-2012-00280","article-title":"Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer","volume":"12","author":"Tang","year":"2013","journal-title":"Cancer Biomark"},{"key":"key20200714083855_b63-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3892\/ijmm.2012.880","article-title":"Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma","volume":"29","author":"Li","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20200714083855_b64-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00432-012-1353-5","article-title":"Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer","volume":"139","author":"Zhong","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20200714083855_b65-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1158\/0008-5472.CAN-08-4977","article-title":"Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization","volume":"69","author":"Novak","year":"2009","journal-title":"Cancer Res"},{"key":"key20200714083855_b66-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"e2112","DOI":"10.7717\/peerj.2112","article-title":"Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer","volume":"4","author":"Pimson","year":"2016","journal-title":"Peer J"},{"key":"key20200714083855_b67-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3233\/CBM-150496","article-title":"Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer","volume":"15","author":"Hou","year":"2015","journal-title":"Cancer Biomark"},{"key":"key20200714083855_b68-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"516","DOI":"10.12659\/MSM.897179","article-title":"Prognostic value of Protocadherin10 (PCDH10) methylation in serum of prostate cancer patients","volume":"22","author":"Deng","year":"2016","journal-title":"Med Sci Monit"},{"key":"key20200714083855_b69-ol-0-0-9214","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.02.006","article-title":"Sperm epigenetics and influence of environmental factors","author":"Donkin","year":"2018","journal-title":"Mol Metab"},{"key":"key20200714083855_b70-ol-0-0-9214","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13148-018-0446-7","article-title":"Endurance training remodels sperm-borne small RNA expression and methylation at neurological gene hotspots","volume":"10","author":"Ingerslev","year":"2018","journal-title":"Clin Epigenetics"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:38:21Z","timestamp":1594719501000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":70,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9214","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]}}}